SPECT Radiopharmaceuticals Market Report

Global SPECT Radiopharmaceuticals Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 07, 2022
  • PAGES：148
  • REPORT CODE：GMM799494
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • SPECT Radiopharmaceuticals market report explains the definition, types, applications, major countries, and major players of the SPECT Radiopharmaceuticals market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GE Healthcare (UK)

    • Advanced Accelerator Applications SA (France)

    • Bracco Imaging SpA (Italy)

    • Mallinckrodt plc (Ireland)

    • Eczacibasi-Monrol Nuclear Products (Turkey)

    • Bayer Healthcare (Germany)

    • Cardinal Health Inc (US)

    • Lantheus Medical Imaging Inc (US)

    • IBA Molecular Imaging (Belgium)

    • Nordion Inc (Canada)

    By Type:

    • Tc-99

    • Tl-201

    • Ga-67

    • I-123

    • Others

    By End-User:

    • Diagnostics

    • Therapeutics

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global SPECT Radiopharmaceuticals Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 SPECT Radiopharmaceuticals Outlook to 2028- Original Forecasts

    • 2.2 SPECT Radiopharmaceuticals Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term SPECT Radiopharmaceuticals Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global SPECT Radiopharmaceuticals Market- Recent Developments

    • 6.1 SPECT Radiopharmaceuticals Market News and Developments

    • 6.2 SPECT Radiopharmaceuticals Market Deals Landscape

    7 SPECT Radiopharmaceuticals Raw Materials and Cost Structure Analysis

    • 7.1 SPECT Radiopharmaceuticals Key Raw Materials

    • 7.2 SPECT Radiopharmaceuticals Price Trend of Key Raw Materials

    • 7.3 SPECT Radiopharmaceuticals Key Suppliers of Raw Materials

    • 7.4 SPECT Radiopharmaceuticals Market Concentration Rate of Raw Materials

    • 7.5 SPECT Radiopharmaceuticals Cost Structure Analysis

      • 7.5.1 SPECT Radiopharmaceuticals Raw Materials Analysis

      • 7.5.2 SPECT Radiopharmaceuticals Labor Cost Analysis

      • 7.5.3 SPECT Radiopharmaceuticals Manufacturing Expenses Analysis

    8 Global SPECT Radiopharmaceuticals Import and Export Analysis (Top 10 Countries)

    • 8.1 Global SPECT Radiopharmaceuticals Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global SPECT Radiopharmaceuticals Export by Region (Top 10 Countries) (2017-2028)

    9 Global SPECT Radiopharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global SPECT Radiopharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tc-99 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tl-201 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Ga-67 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global I-123 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global SPECT Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Therapeutics Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise SPECT Radiopharmaceuticals Market Analysis and Outlook till 2022

    • 10.1 Global SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.2.2 Canada SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.2.3 Mexico SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.2 UK SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.3 Spain SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.4 Belgium SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.5 France SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.6 Italy SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.7 Denmark SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.8 Finland SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.9 Norway SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.10 Sweden SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.11 Poland SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.12 Russia SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.13 Turkey SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.2 Japan SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.3 India SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.4 South Korea SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.5 Pakistan SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.6 Bangladesh SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.7 Indonesia SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.8 Thailand SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.9 Singapore SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.10 Malaysia SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.11 Philippines SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.12 Vietnam SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.2 Colombia SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.3 Chile SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.4 Argentina SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.5 Venezuela SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.6 Peru SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.7 Puerto Rico SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.8 Ecuador SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.2 Kuwait SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.3 Oman SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.4 Qatar SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.5 Saudi Arabia SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.6 United Arab Emirates SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.7.2 South Africa SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.7.3 Egypt SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.7.4 Algeria SPECT Radiopharmaceuticals Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia SPECT Radiopharmaceuticals Consumption (2017-2022)

      • 10.8.2 New Zealand SPECT Radiopharmaceuticals Consumption (2017-2022)

    11 Global SPECT Radiopharmaceuticals Competitive Analysis

    • 11.1 GE Healthcare (UK)

      • 11.1.1 GE Healthcare (UK) Company Details

      • 11.1.2 GE Healthcare (UK) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GE Healthcare (UK) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.1.4 GE Healthcare (UK) SPECT Radiopharmaceuticals Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Advanced Accelerator Applications SA (France)

      • 11.2.1 Advanced Accelerator Applications SA (France) Company Details

      • 11.2.2 Advanced Accelerator Applications SA (France) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Advanced Accelerator Applications SA (France) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.2.4 Advanced Accelerator Applications SA (France) SPECT Radiopharmaceuticals Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bracco Imaging SpA (Italy)

      • 11.3.1 Bracco Imaging SpA (Italy) Company Details

      • 11.3.2 Bracco Imaging SpA (Italy) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bracco Imaging SpA (Italy) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.3.4 Bracco Imaging SpA (Italy) SPECT Radiopharmaceuticals Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Mallinckrodt plc (Ireland)

      • 11.4.1 Mallinckrodt plc (Ireland) Company Details

      • 11.4.2 Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.4.4 Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Eczacibasi-Monrol Nuclear Products (Turkey)

      • 11.5.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Details

      • 11.5.2 Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.5.4 Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Bayer Healthcare (Germany)

      • 11.6.1 Bayer Healthcare (Germany) Company Details

      • 11.6.2 Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.6.4 Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Cardinal Health Inc (US)

      • 11.7.1 Cardinal Health Inc (US) Company Details

      • 11.7.2 Cardinal Health Inc (US) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Cardinal Health Inc (US) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.7.4 Cardinal Health Inc (US) SPECT Radiopharmaceuticals Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Lantheus Medical Imaging Inc (US)

      • 11.8.1 Lantheus Medical Imaging Inc (US) Company Details

      • 11.8.2 Lantheus Medical Imaging Inc (US) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Lantheus Medical Imaging Inc (US) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.8.4 Lantheus Medical Imaging Inc (US) SPECT Radiopharmaceuticals Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 IBA Molecular Imaging (Belgium)

      • 11.9.1 IBA Molecular Imaging (Belgium) Company Details

      • 11.9.2 IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.9.4 IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Nordion Inc (Canada)

      • 11.10.1 Nordion Inc (Canada) Company Details

      • 11.10.2 Nordion Inc (Canada) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Nordion Inc (Canada) SPECT Radiopharmaceuticals Main Business and Markets Served

      • 11.10.4 Nordion Inc (Canada) SPECT Radiopharmaceuticals Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global SPECT Radiopharmaceuticals Market Outlook by Types and Applications to 2028

    • 12.1 Global SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Tc-99 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Tl-201 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Ga-67 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global I-123 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise SPECT Radiopharmaceuticals Market Analysis and Outlook to 2028

    • 13.1 Global SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.2.2 Canada SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.2.3 Mexico SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.2 UK SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.3 Spain SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.4 Belgium SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.5 France SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.6 Italy SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.7 Denmark SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.8 Finland SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.9 Norway SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.10 Sweden SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.11 Poland SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.12 Russia SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.13 Turkey SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.2 Japan SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.3 India SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.4 South Korea SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.8 Thailand SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.9 Singapore SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.11 Philippines SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.2 Colombia SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.3 Chile SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.4 Argentina SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.6 Peru SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.3 Oman SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.4 Qatar SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.7.2 South Africa SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.7.3 Egypt SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.7.4 Algeria SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand SPECT Radiopharmaceuticals Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of SPECT Radiopharmaceuticals

    • Figure of SPECT Radiopharmaceuticals Picture

    • Table Global SPECT Radiopharmaceuticals Import by Region (Top 10 Countries) (2017-2028)

    • Table Global SPECT Radiopharmaceuticals Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Tc-99 Consumption and Growth Rate (2017-2022)

    • Figure Global Tl-201 Consumption and Growth Rate (2017-2022)

    • Figure Global Ga-67 Consumption and Growth Rate (2017-2022)

    • Figure Global I-123 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Table North America SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure United States SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Canada SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Mexico SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Germany SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure UK SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Spain SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Belgium SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure France SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Italy SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Denmark SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Finland SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Norway SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Sweden SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Poland SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Russia SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Turkey SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table APAC SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure China SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Pakistan SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Indonesia SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Thailand SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Singapore SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Malaysia SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Philippines SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Vietnam SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table South America SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Brazil SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Colombia SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Chile SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Argentina SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Venezuela SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Peru SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Ecuador SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table GCC SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Bahrain SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Kuwait SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Oman SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Qatar SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Africa SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Nigeria SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Africa SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Egypt SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Algeria SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Oceania SPECT Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Australia SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure New Zealand SPECT Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table GE Healthcare (UK) Company Details

    • Table GE Healthcare (UK) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare (UK) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table GE Healthcare (UK) SPECT Radiopharmaceuticals Product Portfolio

    • Table Advanced Accelerator Applications SA (France) Company Details

    • Table Advanced Accelerator Applications SA (France) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Accelerator Applications SA (France) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Advanced Accelerator Applications SA (France) SPECT Radiopharmaceuticals Product Portfolio

    • Table Bracco Imaging SpA (Italy) Company Details

    • Table Bracco Imaging SpA (Italy) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging SpA (Italy) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Bracco Imaging SpA (Italy) SPECT Radiopharmaceuticals Product Portfolio

    • Table Mallinckrodt plc (Ireland) Company Details

    • Table Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Mallinckrodt plc (Ireland) SPECT Radiopharmaceuticals Product Portfolio

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) Company Details

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) SPECT Radiopharmaceuticals Product Portfolio

    • Table Bayer Healthcare (Germany) Company Details

    • Table Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Bayer Healthcare (Germany) SPECT Radiopharmaceuticals Product Portfolio

    • Table Cardinal Health Inc (US) Company Details

    • Table Cardinal Health Inc (US) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health Inc (US) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Cardinal Health Inc (US) SPECT Radiopharmaceuticals Product Portfolio

    • Table Lantheus Medical Imaging Inc (US) Company Details

    • Table Lantheus Medical Imaging Inc (US) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Inc (US) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Lantheus Medical Imaging Inc (US) SPECT Radiopharmaceuticals Product Portfolio

    • Table IBA Molecular Imaging (Belgium) Company Details

    • Table IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table IBA Molecular Imaging (Belgium) SPECT Radiopharmaceuticals Product Portfolio

    • Table Nordion Inc (Canada) Company Details

    • Table Nordion Inc (Canada) SPECT Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Inc (Canada) SPECT Radiopharmaceuticals Main Business and Markets Served

    • Table Nordion Inc (Canada) SPECT Radiopharmaceuticals Product Portfolio

    • Figure Global Tc-99 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tl-201 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ga-67 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global I-123 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Table North America SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Germany SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure France SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure China SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table South America SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Brazil SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Bahrain SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Nigeria SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania SPECT Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Australia SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand SPECT Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US